Provectus Pharmaceutical Inc. (PVCT)
OTC: Health Care
$0.90
0.04 | 4.67%
0.04 | 4.67%
Today's Range:
0.88 -
0.92
PVCT Avg. Daily Volume:
118,200
05/30/12 - 1:27 PM ET
TRADE NOW
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 0.86 |
| 52 Week High | 1.10 |
| 52 Week Low | 0.67 |
| Avg. Daily Vol. (Mil) | 0.12 |
| Beta (3 year) | 0.69 |
| Share Related Items | |
| Mkt Cap (Mil) | 96.34 |
| Shares Out (Mil) | 112.03 |
| Float (Mil) | 102.62 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 5.30 |
| Current Ratio | 5.30 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 0.00 |
| Price/Book | 15.58 |
| Price/Cash Flow | -5.20 |
| Per Share Data | |
| Earnings | -0.17 |
| Sales | 0.00 |
| Book Value | 0.06 |
| Cash Flow | -0.16 |
| Business Summary | |
|---|---|
| Provectus Pharmaceutical, Inc. a development-stage biopharmaceutical company focuses on developing products for the treatment of psoriasis, topical diseases and certain forms of cancer including recurrent breast carcinoma and liver cancer. | |
| General Information | |
| 7327 Oak Ridge Highway
Suite A Knoxville, TN 37931 |
|
| www.pvct.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 4 | |
| CEO: H. Craig Dees,PhD | |
| Short Interest | |
| Current Month (Mil) | 0.00 |
| Previous Month (Mil) | 0.00 |
| Short Interest Ratio (Days) | 0.00 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -180.90 |
| Return on Investments | -305.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,445.59 | 1,316.27 | 2,840.66 | 16.29 |
Oil *
103.44
|
|
DOWN
135.10 |
DOWN
16.15 |
DOWN
30.33 |
DOWN
1.02 |
10 Yr
1.63%
SPDR Gold
151.89
|
|
-1.07%
|
-1.21%
|
-1.06%
|
-5.89%
|
Data delayed 20 minutes |
Connect with TheStreet